upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. Company has solid earnings quality and can grow the dividend faster than its peers. $19 price target.
downgraded at BMO to Market Perform, BMO Capital said. $40 price target. NGL pricing could remain a headwind.
downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $48 price target.
Universal Health Services
rated new Neutral at UBS. $43 price target. Strong behavioral segment results building on PSI acquisition.
UnitedHealth rated new Buy at Cantor Fitzgerald. $70 price target. Company is seeing above-average enrollment growth and can deliver solid earnings growth.
downgraded at Argus from Buy to Hold, Argus said. Alliance Boots purchase complicates the company's business model.
rated new Buy at Cantor. $104 price target. Company should continue to execute at peak levels.
rated new Hold at Cantor. $75 price target. Company still needs to show that enrollment and earnings can improve.
downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Valuation call; as the stock is up 8% this month, ahead of the Supreme Court ruling on healthcare reform.
STOCK COMMENTS / EPS CHANGES
(ADBE - Get Report)
numbers lowered at Credit Suisse. ADBE estimates were cut through 2014, Credit Suisse said. Company is seeing slower growth in digital marketing. Neutral rating and new $30 price target.
estimates, target raised at Morgan Stanley. Shares of DFS now seen reaching $39, according to Morgan Stanley. Estimates also increased, given better credit trends. The company may also repurchase more shares. Equal-weight rating.
Discover Financial Services numbers raised at Jefferies. Shares of DFS now seen reaching $40, Jefferies said. Estimates also raised on slower card yield compression. Buy rating.
estimates, target increased at Sterne Agee. FDX estimates were raised through 2013, Sterne Agee said. Company is cutting costs across the board. Buy rating and new $120 price target.
FedEx numbers lowered at Jefferies. Shares of FDX now seen reaching $103, Jefferies said. Estimates also lowered on lower expectations for 2013. Hold rating.